Coughlin Timothy

Coughlin Timothy is listed in filings as Director at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX), aTyr Pharma, Inc. (ATYR), and ADC Therapeutics S.A. (ADCT). The current snapshot covers public activity from May 2, 2025 to May 21, 2026. Reported amounts are shown as $507.1K to $47.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.